Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENDOSTATIN Cause Myelosuppression? 21 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Myelosuppression have been filed in association with ENDOSTATIN. This represents 25.6% of all adverse event reports for ENDOSTATIN.

21
Reports of Myelosuppression with ENDOSTATIN
25.6%
of all ENDOSTATIN reports
0
Deaths
9
Hospitalizations

How Dangerous Is Myelosuppression From ENDOSTATIN?

Of the 21 reports, 9 (42.9%) required hospitalization, and 1 (4.8%) were considered life-threatening.

Is Myelosuppression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENDOSTATIN. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does ENDOSTATIN Cause?

Nausea (10) Bone marrow failure (7) Gastrointestinal disorder (7) Hepatic function abnormal (7) White blood cell count decreased (7) Disease progression (6) Hypertension (6) Leukopenia (6) Vomiting (6) Gastrointestinal toxicity (5)

What Other Drugs Cause Myelosuppression?

CYCLOPHOSPHAMIDE (3,603) CARBOPLATIN (2,624) TRASTUZUMAB (2,552) PACLITAXEL (2,522) TISLELIZUMAB (2,142) CYTARABINE (1,869) VENETOCLAX (1,864) CISPLATIN (1,849) BEVACIZUMAB (1,744) SODIUM